ozempic semaglutide mechanism of action GLP−1 receptor agonists for the treatment obesity: Role as a promising approach Tirzepatide (MOUNJARO®/ZEPBOUND) vs Semaglutide (OZEMPIC®/WEGOVY®)

Sermorelin and ipamorelin naturally stimulate your bodys growth hormone production

As Seen on CNN: You Cannot Ignore the GLP1 Effect A January 2026 CNN Smerconish segment featuring consumer behavior analyst Ali Furman laid it out clearly (video): People on these medications consume ~40% fewer calories and are spending about 5% less at quick-service restaurants. The GLP1 customer isnt eating out less theyre eating differently. Ali Furman, CNN Smerconish - Ali Furman, US Consumer Markets Industry Leader, PwC Furman shared that household penetration of GLP1s rose from 9% to 20% in 2025 , and with oral versions expected soon, usage will likely climb even further

However, when combined with insulin or sulphonylureas, the risk of hypoglycaemia increases significantly and dose adjustments of these agents may be needed

Heres everything you need to know to make an informed decision